Global Opioid Narcotics Market Growth 2026-2032
The global Opioid Narcotics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Opioids are a class of drugs derived from the poppy plant or obtained through synthetic routes. They are mainly used to relieve moderate to severe pain and, in some cases, for anesthesia. These drugs bind to opioid receptors in the central nervous system to exert a variety of effects such as analgesia and sedation.
United States market for Opioid Narcotics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Opioid Narcotics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Opioid Narcotics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Opioid Narcotics players cover Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Opioid Narcotics Industry Forecast? looks at past sales and reviews total world Opioid Narcotics sales in 2025, providing a comprehensive analysis by region and market sector of projected Opioid Narcotics sales for 2026 through 2032. With Opioid Narcotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Narcotics industry.
This Insight Report provides a comprehensive analysis of the global Opioid Narcotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid Narcotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Opioid Narcotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Narcotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Narcotics.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Narcotics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Opioid Narcotics market?
What factors are driving Opioid Narcotics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioid Narcotics market opportunities vary by end market size?
How does Opioid Narcotics break out by Type, by Application?
Opioids are a class of drugs derived from the poppy plant or obtained through synthetic routes. They are mainly used to relieve moderate to severe pain and, in some cases, for anesthesia. These drugs bind to opioid receptors in the central nervous system to exert a variety of effects such as analgesia and sedation.
United States market for Opioid Narcotics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Opioid Narcotics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Opioid Narcotics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Opioid Narcotics players cover Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Opioid Narcotics Industry Forecast? looks at past sales and reviews total world Opioid Narcotics sales in 2025, providing a comprehensive analysis by region and market sector of projected Opioid Narcotics sales for 2026 through 2032. With Opioid Narcotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Narcotics industry.
This Insight Report provides a comprehensive analysis of the global Opioid Narcotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid Narcotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Opioid Narcotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Narcotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Narcotics.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Narcotics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Fentanyl
- Remifentanil
- Sufentanil
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Yichang Renfu Pharmaceutical Co., Ltd.
- Jiangsu Enhua Pharmaceutical Co., Ltd.
- Henan Lingrui Pharmaceutical Co., Ltd.
- Sinopharm Group Industrial Co., Ltd. Langfang Branch
- Changzhou Siyao Pharmaceutical Co., Ltd.
- Pfizer
- Fresenius Kabi
- Daiichi Sankyo
- Abbott
- GSK
- Reig Jofre
- AcelRx Pharmaceuticals, Inc
What is the 10-year outlook for the global Opioid Narcotics market?
What factors are driving Opioid Narcotics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioid Narcotics market opportunities vary by end market size?
How does Opioid Narcotics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid Narcotics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Opioid Narcotics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Opioid Narcotics by Country/Region, 2021, 2025 & 2032
2.2 Opioid Narcotics Segment by Type
2.2.1 Fentanyl
2.2.2 Remifentanil
2.2.3 Sufentanil
2.2.4 Opioid Narcotics Sales by Type
2.2.4.1 Global Opioid Narcotics Sales Market Share by Type (2021-2026)
2.2.4.2 Global Opioid Narcotics Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Opioid Narcotics Sale Price by Type (2021-2026)
2.3 Opioid Narcotics Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Opioid Narcotics Sales by Application
2.3.4.1 Global Opioid Narcotics Sale Market Share by Application (2021-2026)
2.3.4.2 Global Opioid Narcotics Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Opioid Narcotics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Opioid Narcotics Breakdown Data by Company
3.1.1 Global Opioid Narcotics Annual Sales by Company (2021-2026)
3.1.2 Global Opioid Narcotics Sales Market Share by Company (2021-2026)
3.2 Global Opioid Narcotics Annual Revenue by Company (2021-2026)
3.2.1 Global Opioid Narcotics Revenue by Company (2021-2026)
3.2.2 Global Opioid Narcotics Revenue Market Share by Company (2021-2026)
3.3 Global Opioid Narcotics Sale Price by Company
3.4 Key Manufacturers Opioid Narcotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Narcotics Product Location Distribution
3.4.2 Players Opioid Narcotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OPIOID NARCOTICS BY GEOGRAPHIC REGION
4.1 World Historic Opioid Narcotics Market Size by Geographic Region (2021-2026)
4.1.1 Global Opioid Narcotics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Opioid Narcotics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Opioid Narcotics Market Size by Country/Region (2021-2026)
4.2.1 Global Opioid Narcotics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Opioid Narcotics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Opioid Narcotics Sales Growth
4.4 APAC Opioid Narcotics Sales Growth
4.5 Europe Opioid Narcotics Sales Growth
4.6 Middle East & Africa Opioid Narcotics Sales Growth
5 AMERICAS
5.1 Americas Opioid Narcotics Sales by Country
5.1.1 Americas Opioid Narcotics Sales by Country (2021-2026)
5.1.2 Americas Opioid Narcotics Revenue by Country (2021-2026)
5.2 Americas Opioid Narcotics Sales by Type (2021-2026)
5.3 Americas Opioid Narcotics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Narcotics Sales by Region
6.1.1 APAC Opioid Narcotics Sales by Region (2021-2026)
6.1.2 APAC Opioid Narcotics Revenue by Region (2021-2026)
6.2 APAC Opioid Narcotics Sales by Type (2021-2026)
6.3 APAC Opioid Narcotics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioid Narcotics by Country
7.1.1 Europe Opioid Narcotics Sales by Country (2021-2026)
7.1.2 Europe Opioid Narcotics Revenue by Country (2021-2026)
7.2 Europe Opioid Narcotics Sales by Type (2021-2026)
7.3 Europe Opioid Narcotics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid Narcotics by Country
8.1.1 Middle East & Africa Opioid Narcotics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Opioid Narcotics Revenue by Country (2021-2026)
8.2 Middle East & Africa Opioid Narcotics Sales by Type (2021-2026)
8.3 Middle East & Africa Opioid Narcotics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Narcotics
10.3 Manufacturing Process Analysis of Opioid Narcotics
10.4 Industry Chain Structure of Opioid Narcotics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Narcotics Distributors
11.3 Opioid Narcotics Customer
12 WORLD FORECAST REVIEW FOR OPIOID NARCOTICS BY GEOGRAPHIC REGION
12.1 Global Opioid Narcotics Market Size Forecast by Region
12.1.1 Global Opioid Narcotics Forecast by Region (2027-2032)
12.1.2 Global Opioid Narcotics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Opioid Narcotics Forecast by Type (2027-2032)
12.7 Global Opioid Narcotics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Yichang Renfu Pharmaceutical Co., Ltd.
13.1.1 Yichang Renfu Pharmaceutical Co., Ltd. Company Information
13.1.2 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
13.1.3 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Yichang Renfu Pharmaceutical Co., Ltd. Main Business Overview
13.1.5 Yichang Renfu Pharmaceutical Co., Ltd. Latest Developments
13.2 Jiangsu Enhua Pharmaceutical Co., Ltd.
13.2.1 Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information
13.2.2 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
13.2.3 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Jiangsu Enhua Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Jiangsu Enhua Pharmaceutical Co., Ltd. Latest Developments
13.3 Henan Lingrui Pharmaceutical Co., Ltd.
13.3.1 Henan Lingrui Pharmaceutical Co., Ltd. Company Information
13.3.2 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
13.3.3 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Henan Lingrui Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Henan Lingrui Pharmaceutical Co., Ltd. Latest Developments
13.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch
13.4.1 Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information
13.4.2 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolios and Specifications
13.4.3 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch Main Business Overview
13.4.5 Sinopharm Group Industrial Co., Ltd. Langfang Branch Latest Developments
13.5 Changzhou Siyao Pharmaceutical Co., Ltd.
13.5.1 Changzhou Siyao Pharmaceutical Co., Ltd. Company Information
13.5.2 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
13.5.3 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Changzhou Siyao Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Changzhou Siyao Pharmaceutical Co., Ltd. Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Opioid Narcotics Product Portfolios and Specifications
13.6.3 Pfizer Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Opioid Narcotics Product Portfolios and Specifications
13.7.3 Fresenius Kabi Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Daiichi Sankyo
13.8.1 Daiichi Sankyo Company Information
13.8.2 Daiichi Sankyo Opioid Narcotics Product Portfolios and Specifications
13.8.3 Daiichi Sankyo Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Daiichi Sankyo Main Business Overview
13.8.5 Daiichi Sankyo Latest Developments
13.9 Abbott
13.9.1 Abbott Company Information
13.9.2 Abbott Opioid Narcotics Product Portfolios and Specifications
13.9.3 Abbott Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Abbott Main Business Overview
13.9.5 Abbott Latest Developments
13.10 GSK
13.10.1 GSK Company Information
13.10.2 GSK Opioid Narcotics Product Portfolios and Specifications
13.10.3 GSK Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 GSK Main Business Overview
13.10.5 GSK Latest Developments
13.11 Reig Jofre
13.11.1 Reig Jofre Company Information
13.11.2 Reig Jofre Opioid Narcotics Product Portfolios and Specifications
13.11.3 Reig Jofre Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Reig Jofre Main Business Overview
13.11.5 Reig Jofre Latest Developments
13.12 AcelRx Pharmaceuticals, Inc
13.12.1 AcelRx Pharmaceuticals, Inc Company Information
13.12.2 AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolios and Specifications
13.12.3 AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 AcelRx Pharmaceuticals, Inc Main Business Overview
13.12.5 AcelRx Pharmaceuticals, Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid Narcotics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Opioid Narcotics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Opioid Narcotics by Country/Region, 2021, 2025 & 2032
2.2 Opioid Narcotics Segment by Type
2.2.1 Fentanyl
2.2.2 Remifentanil
2.2.3 Sufentanil
2.2.4 Opioid Narcotics Sales by Type
2.2.4.1 Global Opioid Narcotics Sales Market Share by Type (2021-2026)
2.2.4.2 Global Opioid Narcotics Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Opioid Narcotics Sale Price by Type (2021-2026)
2.3 Opioid Narcotics Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Opioid Narcotics Sales by Application
2.3.4.1 Global Opioid Narcotics Sale Market Share by Application (2021-2026)
2.3.4.2 Global Opioid Narcotics Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Opioid Narcotics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Opioid Narcotics Breakdown Data by Company
3.1.1 Global Opioid Narcotics Annual Sales by Company (2021-2026)
3.1.2 Global Opioid Narcotics Sales Market Share by Company (2021-2026)
3.2 Global Opioid Narcotics Annual Revenue by Company (2021-2026)
3.2.1 Global Opioid Narcotics Revenue by Company (2021-2026)
3.2.2 Global Opioid Narcotics Revenue Market Share by Company (2021-2026)
3.3 Global Opioid Narcotics Sale Price by Company
3.4 Key Manufacturers Opioid Narcotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Narcotics Product Location Distribution
3.4.2 Players Opioid Narcotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OPIOID NARCOTICS BY GEOGRAPHIC REGION
4.1 World Historic Opioid Narcotics Market Size by Geographic Region (2021-2026)
4.1.1 Global Opioid Narcotics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Opioid Narcotics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Opioid Narcotics Market Size by Country/Region (2021-2026)
4.2.1 Global Opioid Narcotics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Opioid Narcotics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Opioid Narcotics Sales Growth
4.4 APAC Opioid Narcotics Sales Growth
4.5 Europe Opioid Narcotics Sales Growth
4.6 Middle East & Africa Opioid Narcotics Sales Growth
5 AMERICAS
5.1 Americas Opioid Narcotics Sales by Country
5.1.1 Americas Opioid Narcotics Sales by Country (2021-2026)
5.1.2 Americas Opioid Narcotics Revenue by Country (2021-2026)
5.2 Americas Opioid Narcotics Sales by Type (2021-2026)
5.3 Americas Opioid Narcotics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Narcotics Sales by Region
6.1.1 APAC Opioid Narcotics Sales by Region (2021-2026)
6.1.2 APAC Opioid Narcotics Revenue by Region (2021-2026)
6.2 APAC Opioid Narcotics Sales by Type (2021-2026)
6.3 APAC Opioid Narcotics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioid Narcotics by Country
7.1.1 Europe Opioid Narcotics Sales by Country (2021-2026)
7.1.2 Europe Opioid Narcotics Revenue by Country (2021-2026)
7.2 Europe Opioid Narcotics Sales by Type (2021-2026)
7.3 Europe Opioid Narcotics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid Narcotics by Country
8.1.1 Middle East & Africa Opioid Narcotics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Opioid Narcotics Revenue by Country (2021-2026)
8.2 Middle East & Africa Opioid Narcotics Sales by Type (2021-2026)
8.3 Middle East & Africa Opioid Narcotics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Narcotics
10.3 Manufacturing Process Analysis of Opioid Narcotics
10.4 Industry Chain Structure of Opioid Narcotics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Narcotics Distributors
11.3 Opioid Narcotics Customer
12 WORLD FORECAST REVIEW FOR OPIOID NARCOTICS BY GEOGRAPHIC REGION
12.1 Global Opioid Narcotics Market Size Forecast by Region
12.1.1 Global Opioid Narcotics Forecast by Region (2027-2032)
12.1.2 Global Opioid Narcotics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Opioid Narcotics Forecast by Type (2027-2032)
12.7 Global Opioid Narcotics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Yichang Renfu Pharmaceutical Co., Ltd.
13.1.1 Yichang Renfu Pharmaceutical Co., Ltd. Company Information
13.1.2 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
13.1.3 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Yichang Renfu Pharmaceutical Co., Ltd. Main Business Overview
13.1.5 Yichang Renfu Pharmaceutical Co., Ltd. Latest Developments
13.2 Jiangsu Enhua Pharmaceutical Co., Ltd.
13.2.1 Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information
13.2.2 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
13.2.3 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Jiangsu Enhua Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Jiangsu Enhua Pharmaceutical Co., Ltd. Latest Developments
13.3 Henan Lingrui Pharmaceutical Co., Ltd.
13.3.1 Henan Lingrui Pharmaceutical Co., Ltd. Company Information
13.3.2 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
13.3.3 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Henan Lingrui Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Henan Lingrui Pharmaceutical Co., Ltd. Latest Developments
13.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch
13.4.1 Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information
13.4.2 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolios and Specifications
13.4.3 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch Main Business Overview
13.4.5 Sinopharm Group Industrial Co., Ltd. Langfang Branch Latest Developments
13.5 Changzhou Siyao Pharmaceutical Co., Ltd.
13.5.1 Changzhou Siyao Pharmaceutical Co., Ltd. Company Information
13.5.2 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
13.5.3 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Changzhou Siyao Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Changzhou Siyao Pharmaceutical Co., Ltd. Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Opioid Narcotics Product Portfolios and Specifications
13.6.3 Pfizer Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Opioid Narcotics Product Portfolios and Specifications
13.7.3 Fresenius Kabi Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Daiichi Sankyo
13.8.1 Daiichi Sankyo Company Information
13.8.2 Daiichi Sankyo Opioid Narcotics Product Portfolios and Specifications
13.8.3 Daiichi Sankyo Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Daiichi Sankyo Main Business Overview
13.8.5 Daiichi Sankyo Latest Developments
13.9 Abbott
13.9.1 Abbott Company Information
13.9.2 Abbott Opioid Narcotics Product Portfolios and Specifications
13.9.3 Abbott Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Abbott Main Business Overview
13.9.5 Abbott Latest Developments
13.10 GSK
13.10.1 GSK Company Information
13.10.2 GSK Opioid Narcotics Product Portfolios and Specifications
13.10.3 GSK Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 GSK Main Business Overview
13.10.5 GSK Latest Developments
13.11 Reig Jofre
13.11.1 Reig Jofre Company Information
13.11.2 Reig Jofre Opioid Narcotics Product Portfolios and Specifications
13.11.3 Reig Jofre Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Reig Jofre Main Business Overview
13.11.5 Reig Jofre Latest Developments
13.12 AcelRx Pharmaceuticals, Inc
13.12.1 AcelRx Pharmaceuticals, Inc Company Information
13.12.2 AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolios and Specifications
13.12.3 AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 AcelRx Pharmaceuticals, Inc Main Business Overview
13.12.5 AcelRx Pharmaceuticals, Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Opioid Narcotics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Opioid Narcotics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fentanyl
Table 4. Major Players of Remifentanil
Table 5. Major Players of Sufentanil
Table 6. Global Opioid Narcotics Sales by Type (2021-2026) & (K Units)
Table 7. Global Opioid Narcotics Sales Market Share by Type (2021-2026)
Table 8. Global Opioid Narcotics Revenue by Type (2021-2026) & ($ million)
Table 9. Global Opioid Narcotics Revenue Market Share by Type (2021-2026)
Table 10. Global Opioid Narcotics Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Opioid Narcotics Sale by Application (2021-2026) & (K Units)
Table 12. Global Opioid Narcotics Sale Market Share by Application (2021-2026)
Table 13. Global Opioid Narcotics Revenue by Application (2021-2026) & ($ million)
Table 14. Global Opioid Narcotics Revenue Market Share by Application (2021-2026)
Table 15. Global Opioid Narcotics Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Opioid Narcotics Sales by Company (2021-2026) & (K Units)
Table 17. Global Opioid Narcotics Sales Market Share by Company (2021-2026)
Table 18. Global Opioid Narcotics Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Opioid Narcotics Revenue Market Share by Company (2021-2026)
Table 20. Global Opioid Narcotics Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Opioid Narcotics Producing Area Distribution and Sales Area
Table 22. Players Opioid Narcotics Products Offered
Table 23. Opioid Narcotics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Opioid Narcotics Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Opioid Narcotics Sales Market Share Geographic Region (2021-2026)
Table 28. Global Opioid Narcotics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Opioid Narcotics Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Opioid Narcotics Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Opioid Narcotics Sales Market Share by Country/Region (2021-2026)
Table 32. Global Opioid Narcotics Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Opioid Narcotics Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Opioid Narcotics Sales by Country (2021-2026) & (K Units)
Table 35. Americas Opioid Narcotics Sales Market Share by Country (2021-2026)
Table 36. Americas Opioid Narcotics Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Opioid Narcotics Sales by Type (2021-2026) & (K Units)
Table 38. Americas Opioid Narcotics Sales by Application (2021-2026) & (K Units)
Table 39. APAC Opioid Narcotics Sales by Region (2021-2026) & (K Units)
Table 40. APAC Opioid Narcotics Sales Market Share by Region (2021-2026)
Table 41. APAC Opioid Narcotics Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Opioid Narcotics Sales by Type (2021-2026) & (K Units)
Table 43. APAC Opioid Narcotics Sales by Application (2021-2026) & (K Units)
Table 44. Europe Opioid Narcotics Sales by Country (2021-2026) & (K Units)
Table 45. Europe Opioid Narcotics Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Opioid Narcotics Sales by Type (2021-2026) & (K Units)
Table 47. Europe Opioid Narcotics Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Opioid Narcotics Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Opioid Narcotics Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Opioid Narcotics Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Opioid Narcotics Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Opioid Narcotics
Table 53. Key Market Challenges & Risks of Opioid Narcotics
Table 54. Key Industry Trends of Opioid Narcotics
Table 55. Opioid Narcotics Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Opioid Narcotics Distributors List
Table 58. Opioid Narcotics Customer List
Table 59. Global Opioid Narcotics Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Opioid Narcotics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Opioid Narcotics Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Opioid Narcotics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Opioid Narcotics Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Opioid Narcotics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Opioid Narcotics Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Opioid Narcotics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Opioid Narcotics Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Opioid Narcotics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Opioid Narcotics Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Opioid Narcotics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Opioid Narcotics Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Opioid Narcotics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Yichang Renfu Pharmaceutical Co., Ltd. Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 74. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
Table 75. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Yichang Renfu Pharmaceutical Co., Ltd. Main Business
Table 77. Yichang Renfu Pharmaceutical Co., Ltd. Latest Developments
Table 78. Jiangsu Enhua Pharmaceutical Co., Ltd. Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 79. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
Table 80. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Jiangsu Enhua Pharmaceutical Co., Ltd. Main Business
Table 82. Jiangsu Enhua Pharmaceutical Co., Ltd. Latest Developments
Table 83. Henan Lingrui Pharmaceutical Co., Ltd. Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 84. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
Table 85. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Henan Lingrui Pharmaceutical Co., Ltd. Main Business
Table 87. Henan Lingrui Pharmaceutical Co., Ltd. Latest Developments
Table 88. Sinopharm Group Industrial Co., Ltd. Langfang Branch Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 89. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolios and Specifications
Table 90. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Sinopharm Group Industrial Co., Ltd. Langfang Branch Main Business
Table 92. Sinopharm Group Industrial Co., Ltd. Langfang Branch Latest Developments
Table 93. Changzhou Siyao Pharmaceutical Co., Ltd. Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 94. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
Table 95. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Changzhou Siyao Pharmaceutical Co., Ltd. Main Business
Table 97. Changzhou Siyao Pharmaceutical Co., Ltd. Latest Developments
Table 98. Pfizer Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Opioid Narcotics Product Portfolios and Specifications
Table 100. Pfizer Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Fresenius Kabi Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 104. Fresenius Kabi Opioid Narcotics Product Portfolios and Specifications
Table 105. Fresenius Kabi Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Fresenius Kabi Main Business
Table 107. Fresenius Kabi Latest Developments
Table 108. Daiichi Sankyo Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 109. Daiichi Sankyo Opioid Narcotics Product Portfolios and Specifications
Table 110. Daiichi Sankyo Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Daiichi Sankyo Main Business
Table 112. Daiichi Sankyo Latest Developments
Table 113. Abbott Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 114. Abbott Opioid Narcotics Product Portfolios and Specifications
Table 115. Abbott Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Abbott Main Business
Table 117. Abbott Latest Developments
Table 118. GSK Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 119. GSK Opioid Narcotics Product Portfolios and Specifications
Table 120. GSK Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. GSK Main Business
Table 122. GSK Latest Developments
Table 123. Reig Jofre Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 124. Reig Jofre Opioid Narcotics Product Portfolios and Specifications
Table 125. Reig Jofre Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Reig Jofre Main Business
Table 127. Reig Jofre Latest Developments
Table 128. AcelRx Pharmaceuticals, Inc Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 129. AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolios and Specifications
Table 130. AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. AcelRx Pharmaceuticals, Inc Main Business
Table 132. AcelRx Pharmaceuticals, Inc Latest Developments
Table 1. Opioid Narcotics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Opioid Narcotics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fentanyl
Table 4. Major Players of Remifentanil
Table 5. Major Players of Sufentanil
Table 6. Global Opioid Narcotics Sales by Type (2021-2026) & (K Units)
Table 7. Global Opioid Narcotics Sales Market Share by Type (2021-2026)
Table 8. Global Opioid Narcotics Revenue by Type (2021-2026) & ($ million)
Table 9. Global Opioid Narcotics Revenue Market Share by Type (2021-2026)
Table 10. Global Opioid Narcotics Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Opioid Narcotics Sale by Application (2021-2026) & (K Units)
Table 12. Global Opioid Narcotics Sale Market Share by Application (2021-2026)
Table 13. Global Opioid Narcotics Revenue by Application (2021-2026) & ($ million)
Table 14. Global Opioid Narcotics Revenue Market Share by Application (2021-2026)
Table 15. Global Opioid Narcotics Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Opioid Narcotics Sales by Company (2021-2026) & (K Units)
Table 17. Global Opioid Narcotics Sales Market Share by Company (2021-2026)
Table 18. Global Opioid Narcotics Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Opioid Narcotics Revenue Market Share by Company (2021-2026)
Table 20. Global Opioid Narcotics Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Opioid Narcotics Producing Area Distribution and Sales Area
Table 22. Players Opioid Narcotics Products Offered
Table 23. Opioid Narcotics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Opioid Narcotics Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Opioid Narcotics Sales Market Share Geographic Region (2021-2026)
Table 28. Global Opioid Narcotics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Opioid Narcotics Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Opioid Narcotics Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Opioid Narcotics Sales Market Share by Country/Region (2021-2026)
Table 32. Global Opioid Narcotics Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Opioid Narcotics Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Opioid Narcotics Sales by Country (2021-2026) & (K Units)
Table 35. Americas Opioid Narcotics Sales Market Share by Country (2021-2026)
Table 36. Americas Opioid Narcotics Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Opioid Narcotics Sales by Type (2021-2026) & (K Units)
Table 38. Americas Opioid Narcotics Sales by Application (2021-2026) & (K Units)
Table 39. APAC Opioid Narcotics Sales by Region (2021-2026) & (K Units)
Table 40. APAC Opioid Narcotics Sales Market Share by Region (2021-2026)
Table 41. APAC Opioid Narcotics Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Opioid Narcotics Sales by Type (2021-2026) & (K Units)
Table 43. APAC Opioid Narcotics Sales by Application (2021-2026) & (K Units)
Table 44. Europe Opioid Narcotics Sales by Country (2021-2026) & (K Units)
Table 45. Europe Opioid Narcotics Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Opioid Narcotics Sales by Type (2021-2026) & (K Units)
Table 47. Europe Opioid Narcotics Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Opioid Narcotics Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Opioid Narcotics Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Opioid Narcotics Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Opioid Narcotics Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Opioid Narcotics
Table 53. Key Market Challenges & Risks of Opioid Narcotics
Table 54. Key Industry Trends of Opioid Narcotics
Table 55. Opioid Narcotics Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Opioid Narcotics Distributors List
Table 58. Opioid Narcotics Customer List
Table 59. Global Opioid Narcotics Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Opioid Narcotics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Opioid Narcotics Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Opioid Narcotics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Opioid Narcotics Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Opioid Narcotics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Opioid Narcotics Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Opioid Narcotics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Opioid Narcotics Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Opioid Narcotics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Opioid Narcotics Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Opioid Narcotics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Opioid Narcotics Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Opioid Narcotics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Yichang Renfu Pharmaceutical Co., Ltd. Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 74. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
Table 75. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Yichang Renfu Pharmaceutical Co., Ltd. Main Business
Table 77. Yichang Renfu Pharmaceutical Co., Ltd. Latest Developments
Table 78. Jiangsu Enhua Pharmaceutical Co., Ltd. Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 79. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
Table 80. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Jiangsu Enhua Pharmaceutical Co., Ltd. Main Business
Table 82. Jiangsu Enhua Pharmaceutical Co., Ltd. Latest Developments
Table 83. Henan Lingrui Pharmaceutical Co., Ltd. Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 84. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
Table 85. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Henan Lingrui Pharmaceutical Co., Ltd. Main Business
Table 87. Henan Lingrui Pharmaceutical Co., Ltd. Latest Developments
Table 88. Sinopharm Group Industrial Co., Ltd. Langfang Branch Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 89. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolios and Specifications
Table 90. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Sinopharm Group Industrial Co., Ltd. Langfang Branch Main Business
Table 92. Sinopharm Group Industrial Co., Ltd. Langfang Branch Latest Developments
Table 93. Changzhou Siyao Pharmaceutical Co., Ltd. Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 94. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolios and Specifications
Table 95. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Changzhou Siyao Pharmaceutical Co., Ltd. Main Business
Table 97. Changzhou Siyao Pharmaceutical Co., Ltd. Latest Developments
Table 98. Pfizer Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Opioid Narcotics Product Portfolios and Specifications
Table 100. Pfizer Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Fresenius Kabi Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 104. Fresenius Kabi Opioid Narcotics Product Portfolios and Specifications
Table 105. Fresenius Kabi Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Fresenius Kabi Main Business
Table 107. Fresenius Kabi Latest Developments
Table 108. Daiichi Sankyo Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 109. Daiichi Sankyo Opioid Narcotics Product Portfolios and Specifications
Table 110. Daiichi Sankyo Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Daiichi Sankyo Main Business
Table 112. Daiichi Sankyo Latest Developments
Table 113. Abbott Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 114. Abbott Opioid Narcotics Product Portfolios and Specifications
Table 115. Abbott Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Abbott Main Business
Table 117. Abbott Latest Developments
Table 118. GSK Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 119. GSK Opioid Narcotics Product Portfolios and Specifications
Table 120. GSK Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. GSK Main Business
Table 122. GSK Latest Developments
Table 123. Reig Jofre Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 124. Reig Jofre Opioid Narcotics Product Portfolios and Specifications
Table 125. Reig Jofre Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Reig Jofre Main Business
Table 127. Reig Jofre Latest Developments
Table 128. AcelRx Pharmaceuticals, Inc Basic Information, Opioid Narcotics Manufacturing Base, Sales Area and Its Competitors
Table 129. AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolios and Specifications
Table 130. AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. AcelRx Pharmaceuticals, Inc Main Business
Table 132. AcelRx Pharmaceuticals, Inc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Opioid Narcotics
Figure 2. Opioid Narcotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Narcotics Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Opioid Narcotics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Opioid Narcotics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Opioid Narcotics Sales Market Share by Country/Region (2025)
Figure 10. Opioid Narcotics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fentanyl
Figure 12. Product Picture of Remifentanil
Figure 13. Product Picture of Sufentanil
Figure 14. Global Opioid Narcotics Sales Market Share by Type in 2026
Figure 15. Global Opioid Narcotics Revenue Market Share by Type (2021-2026)
Figure 16. Opioid Narcotics Consumed in Hospital
Figure 17. Global Opioid Narcotics Market: Hospital (2021-2026) & (K Units)
Figure 18. Opioid Narcotics Consumed in Clinic
Figure 19. Global Opioid Narcotics Market: Clinic (2021-2026) & (K Units)
Figure 20. Opioid Narcotics Consumed in Other
Figure 21. Global Opioid Narcotics Market: Other (2021-2026) & (K Units)
Figure 22. Global Opioid Narcotics Sale Market Share by Application (2025)
Figure 23. Global Opioid Narcotics Revenue Market Share by Application in 2026
Figure 24. Opioid Narcotics Sales by Company in 2026 (K Units)
Figure 25. Global Opioid Narcotics Sales Market Share by Company in 2026
Figure 26. Opioid Narcotics Revenue by Company in 2026 ($ millions)
Figure 27. Global Opioid Narcotics Revenue Market Share by Company in 2026
Figure 28. Global Opioid Narcotics Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Opioid Narcotics Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Opioid Narcotics Sales 2021-2026 (K Units)
Figure 31. Americas Opioid Narcotics Revenue 2021-2026 ($ millions)
Figure 32. APAC Opioid Narcotics Sales 2021-2026 (K Units)
Figure 33. APAC Opioid Narcotics Revenue 2021-2026 ($ millions)
Figure 34. Europe Opioid Narcotics Sales 2021-2026 (K Units)
Figure 35. Europe Opioid Narcotics Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Opioid Narcotics Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Opioid Narcotics Revenue 2021-2026 ($ millions)
Figure 38. Americas Opioid Narcotics Sales Market Share by Country in 2026
Figure 39. Americas Opioid Narcotics Revenue Market Share by Country (2021-2026)
Figure 40. Americas Opioid Narcotics Sales Market Share by Type (2021-2026)
Figure 41. Americas Opioid Narcotics Sales Market Share by Application (2021-2026)
Figure 42. United States Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Opioid Narcotics Sales Market Share by Region in 2026
Figure 47. APAC Opioid Narcotics Revenue Market Share by Region (2021-2026)
Figure 48. APAC Opioid Narcotics Sales Market Share by Type (2021-2026)
Figure 49. APAC Opioid Narcotics Sales Market Share by Application (2021-2026)
Figure 50. China Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 54. India Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Opioid Narcotics Sales Market Share by Country in 2026
Figure 58. Europe Opioid Narcotics Revenue Market Share by Country (2021-2026)
Figure 59. Europe Opioid Narcotics Sales Market Share by Type (2021-2026)
Figure 60. Europe Opioid Narcotics Sales Market Share by Application (2021-2026)
Figure 61. Germany Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 62. France Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Opioid Narcotics Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Opioid Narcotics Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Opioid Narcotics Sales Market Share by Application (2021-2026)
Figure 69. Egypt Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Opioid Narcotics in 2026
Figure 75. Manufacturing Process Analysis of Opioid Narcotics
Figure 76. Industry Chain Structure of Opioid Narcotics
Figure 77. Channels of Distribution
Figure 78. Global Opioid Narcotics Sales Market Forecast by Region (2027-2032)
Figure 79. Global Opioid Narcotics Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Opioid Narcotics Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Opioid Narcotics Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Opioid Narcotics Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Opioid Narcotics Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Opioid Narcotics
Figure 2. Opioid Narcotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Narcotics Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Opioid Narcotics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Opioid Narcotics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Opioid Narcotics Sales Market Share by Country/Region (2025)
Figure 10. Opioid Narcotics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fentanyl
Figure 12. Product Picture of Remifentanil
Figure 13. Product Picture of Sufentanil
Figure 14. Global Opioid Narcotics Sales Market Share by Type in 2026
Figure 15. Global Opioid Narcotics Revenue Market Share by Type (2021-2026)
Figure 16. Opioid Narcotics Consumed in Hospital
Figure 17. Global Opioid Narcotics Market: Hospital (2021-2026) & (K Units)
Figure 18. Opioid Narcotics Consumed in Clinic
Figure 19. Global Opioid Narcotics Market: Clinic (2021-2026) & (K Units)
Figure 20. Opioid Narcotics Consumed in Other
Figure 21. Global Opioid Narcotics Market: Other (2021-2026) & (K Units)
Figure 22. Global Opioid Narcotics Sale Market Share by Application (2025)
Figure 23. Global Opioid Narcotics Revenue Market Share by Application in 2026
Figure 24. Opioid Narcotics Sales by Company in 2026 (K Units)
Figure 25. Global Opioid Narcotics Sales Market Share by Company in 2026
Figure 26. Opioid Narcotics Revenue by Company in 2026 ($ millions)
Figure 27. Global Opioid Narcotics Revenue Market Share by Company in 2026
Figure 28. Global Opioid Narcotics Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Opioid Narcotics Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Opioid Narcotics Sales 2021-2026 (K Units)
Figure 31. Americas Opioid Narcotics Revenue 2021-2026 ($ millions)
Figure 32. APAC Opioid Narcotics Sales 2021-2026 (K Units)
Figure 33. APAC Opioid Narcotics Revenue 2021-2026 ($ millions)
Figure 34. Europe Opioid Narcotics Sales 2021-2026 (K Units)
Figure 35. Europe Opioid Narcotics Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Opioid Narcotics Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Opioid Narcotics Revenue 2021-2026 ($ millions)
Figure 38. Americas Opioid Narcotics Sales Market Share by Country in 2026
Figure 39. Americas Opioid Narcotics Revenue Market Share by Country (2021-2026)
Figure 40. Americas Opioid Narcotics Sales Market Share by Type (2021-2026)
Figure 41. Americas Opioid Narcotics Sales Market Share by Application (2021-2026)
Figure 42. United States Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Opioid Narcotics Sales Market Share by Region in 2026
Figure 47. APAC Opioid Narcotics Revenue Market Share by Region (2021-2026)
Figure 48. APAC Opioid Narcotics Sales Market Share by Type (2021-2026)
Figure 49. APAC Opioid Narcotics Sales Market Share by Application (2021-2026)
Figure 50. China Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 54. India Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Opioid Narcotics Sales Market Share by Country in 2026
Figure 58. Europe Opioid Narcotics Revenue Market Share by Country (2021-2026)
Figure 59. Europe Opioid Narcotics Sales Market Share by Type (2021-2026)
Figure 60. Europe Opioid Narcotics Sales Market Share by Application (2021-2026)
Figure 61. Germany Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 62. France Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Opioid Narcotics Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Opioid Narcotics Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Opioid Narcotics Sales Market Share by Application (2021-2026)
Figure 69. Egypt Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Opioid Narcotics Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Opioid Narcotics in 2026
Figure 75. Manufacturing Process Analysis of Opioid Narcotics
Figure 76. Industry Chain Structure of Opioid Narcotics
Figure 77. Channels of Distribution
Figure 78. Global Opioid Narcotics Sales Market Forecast by Region (2027-2032)
Figure 79. Global Opioid Narcotics Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Opioid Narcotics Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Opioid Narcotics Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Opioid Narcotics Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Opioid Narcotics Revenue Market Share Forecast by Application (2027-2032)
